Review decisions - Drug and Health Products Portal

Showing 80 results of 292 total

Summary Safety Review - Mesalazine-containing products - Assessing the Potential Risk of Birth Defects

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00247

Issued / Original Publication Date: 2020-09-24

Summary Safety Review - Single Incision Mini-sling - Assessing the Long-term (beyond 3 years) Safety and Effectiveness

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00246

Issued / Original Publication Date: 2020-09-18

Summary Safety Review - Imbruvica (ibrutinib) - Assessing the Potential Risk of Hemophagocytic Lymphohistiocytosis

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00245

Issued / Original Publication Date: 2020-09-15

Summary Safety Review - Hydromorphone Controlled Release Capsules - Assessing the Increased Risk of Serious Infections Linked to the Injection of the Content of the Capsules into Veins

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00244

Issued / Original Publication Date: 2020-09-10

Summary Safety Review - Methadone-Containing Products Used to Treat Opioid Dependence - Assessing the Potential Risk of Lack of Effect when Switching between Different Products

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00243

Issued / Original Publication Date: 2020-07-17

Summary Safety Review - Brilinta (ticagrelor) - Assessing the Potential Risks of a Worsening of a Slow and Irregular Heartbeat (Bradyarrhythmia) and Partial or Complete Block in the Transmission of Heart Impulses (Second- and Third-Degree Atrioventricular Block)

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00241

Issued / Original Publication Date: 2020-07-06

Summary Safety Review - Picato (ingenol mebutate) - Assessing the Potential Risk of Skin Cancer

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00242

Issued / Original Publication Date: 2020-07-02

Summary Safety Review - Xeljanz and Xeljanz XR (tofacitinib) and Jakavi (ruxolitinib) - Janus Kinase (JAK) inhibitors - Assessing the Potential Risk of Blood Clots in the Deep Veins (Venous Thromboembolic Events)

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00240

Issued / Original Publication Date: 2020-06-18

Summary Safety Review - Ketamine - Assessing the Potential Risk of Liver and Bile Duct Damage

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00239

Issued / Original Publication Date: 2020-06-10

Summary Safety Review - Ibuprofen- Assessing the Potential Risk of Serious Infection of the Deep Layers of the Skin (Necrotising Fasciitis) in Children with Chickenpox Infection

https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00238

Issued / Original Publication Date: 2020-05-29